Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1992-10-14
1995-06-06
Sidberry, Hazel F.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4241841, 4241901, 4241921, 4242341, 530350, 530825, 435 693, 4351721, 4351723, 435 691, 536 234, 536 237, A61K 39102, C12N 1531
Patent
active
054221102
ABSTRACT:
New immunological carrier systems, DNA encoding the same, and the use of these systems, are disclosed. The carrier systems include chimeric proteins which comprise a leukotoxin polypeptide fused to a selected antigen. The leukotoxin functions to increase the immunogenicity of the antigen fused thereto.
REFERENCES:
patent: 4722840 (1988-02-01), Valenzuela et al.
patent: 4867973 (1989-09-01), Goers et al.
patent: 4957739 (1990-09-01), Berget et al.
patent: 4975420 (1990-12-01), Silversides et al.
patent: 5028423 (1991-07-01), Prickett
patent: 5055400 (1991-10-01), Lo et al.
patent: 5238823 (1993-08-01), Potter et al.
Phalipin, A. et al. Gene 55:255-263 (1987).
Buggemann, P. et al BioTechniques 10(2):202-209 (1991).
Forestier, C. et al. 1991. Infection and Immunity 59(11):4212-4220.
Sad, S. et al. 1991. Immunology 74:223-227.
Que et al. 1988. Infection & Immunity 56(10):2645-2649.
Bittle et al., Nature (1982) 298:30-33.
Muller et al., Proc. Natl. Acad. Sci. (1982) 79:569-573.
Schutze et al., J. Immunol. (1985) 135(4):2319-2322.
Lowell et al., Science (1988) 240:800-802.
Morein et al., Nature (1984) 308:457-460.
Neurath et al., Mol. Immunol. (1989) 26(1):53-62.
Redmond et al., Mol. Immunol. (1991) 28(3):269-278.
Kingsman and Kingsman, Vaccine (1988) 6:304-306.
Valenzuela et al., Bio/Technology (1985) 3:323-326.
Delpeyroux et al., Science (1986) 233:472-475.
Clarke et al., Vaccines 88 Ginsberg, H., et al., Eds., (1988) pp. 127-131.
Burke et al., Nature (1988) 332:81-82.
Haynes et al., Bio/Technology (1986) 4:637-641.
Gentry et al., Vet. Immunology and Immunopathology (1985) 9:239-250.
Strathdee and Lo, Infect. Immun. (1987) 55(12):3233-3236.
Lo et al., Infect. Immun. (1985) 50(3):667-671.
Hughes Huw P. A.
Potter Andrew A.
Redmond Mark J.
Sidberry Hazel F.
Tuscan Michael S.
University of Saskatchewan
LandOfFree
Enhanced immunogenicity using leukotoxin chimeras does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhanced immunogenicity using leukotoxin chimeras, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhanced immunogenicity using leukotoxin chimeras will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-985785